Therafectin: BLSI began a Phase III trial

Boston Life Sciences Inc. (BLSI), Waltham, Mass. Product: Therafectin (amiprilose HCl) Indication: Rheumatoid arthritis Status: BLSI began a Phase III trial with the oral therapeutic, which was acquir...